Eversept Partners, LP Aquestive Therapeutics, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.84 - $6.44 $552,000 - $1.93 Million	-300,000 Closed	0 $0
Q1 2020 Nov 08, 2023	SELL	$1.54 - $6.75 $77,000 - $337,500	-50,000 Reduced 14.29%	300,000 $657,000
Q1 2020 May 13, 2020	SELL	$1.54 - $6.75 $77,000 - $337,500	-50,000 Reduced 14.29%	300,000 $657,000
Q4 2019 Nov 08, 2023	BUY	$3.06 - $8.78 $1.07 Million - $3.07 Million	350,000 New	350,000 $2.04 Million
Q4 2019 Feb 13, 2020	BUY	$3.06 - $8.78 $1.07 Million - $3.07 Million	350,000 New	350,000 $2.04 Million

122

46.9M

174K

143K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $177M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.